Chemoprevention of breast and prostate cancers: where do we stand?
Senn
H J
HJ
Tumor and Breast Center ZeTuP, St Gallen, Switzerland.
Morant
R
R
D016588:Anticarcinogenic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control*; D018890:Chemoprevention / Q000009:adverse effects / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011471:Prostatic Neoplasms / Q000517:prevention & control*
D016588:Anticarcinogenic Agents